Novel Neurokinin-1 Antagonists as Antiemetics for the Treatment of Chemotherapy-Induced Emesis
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pharmacology,Oncology
Reference16 articles.
1. Quality of life studies in chemotherapy-induced emesis;Osoba;Oncology,1996
2. On the receiving end–patient perception of the sideeffects of cancer chemotherapy;Coates;Eur J Cancer,1983
3. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone;Campos;J Clin Oncol,2001
4. Treatment of chemotherapyinduced emesis in the 1990s: impact of the 5-HT3 receptor antagonists;Hesketh;Support Care Cancer,1994
5. Comparative review of 5-HT3 receptor antagonists in the treatment of acute chemotherapy-induced nausea and vomiting;Hesketh;Cancer Invest,2000
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of netupitant/palonosetron with 5-hydroxytryptamine-3 receptor antagonist in preventing of chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation;Frontiers in Oncology;2023-11-21
2. Piperazine based antimicrobial polymers: a review;RSC Advances;2021
3. Ruthenium Catalyzed Regioselective β‐C( sp 3 )−H Functionalization of N ‐Alkyl‐ N′ ‐ p– nitrophenyl Substituted Piperazines using Aldehydes as Alkylating Agents;Advanced Synthesis & Catalysis;2020-12-08
4. Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study;Bone Marrow Transplantation;2020-04-28
5. Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew);Frontiers in Pharmacology;2016-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3